Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 1 day agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 1 day agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 2 days agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 1 day agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 2 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 2 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...